Lead Product(s): Peptides
Therapeutic Area: Infections and Infectious Diseases
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: Advanced Computing in Europe
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Funding April 22, 2020
Under the terms of the grant, Nuritas will use its AI platform to classify antiviral peptides as well as cytokine-regulating peptides to build a peptide cocktail for therapy.